• Integrative Medicine Research
• /
• 제3권1호
• /
• pp.4-10
• /
• 2014

Green tea and coffee consumption have been widely popular worldwide. These beverages contain caffeine to activate the central nervous system by adenosine receptor blockade, and due to the caffeine, addiction or tolerance may occur. In addition to this caffeine effect, green tea and coffee consumption have always been at the center of discussions about human health, disease, and longevity. In particular, green tea catechins are involved in many biological activities such as antioxidation and modulation of various cellular lipid and proteins. Thus, they are beneficial against degenerative diseases, including obesity, cancer, cardiovascular diseases, and various inflammatory diseases. Some reports also suggest that daily consumption of tea catechins may help in controlling type 2 diabetes. However, other studies have reported that chronic consumption of green tea may result in hepatic failure, neuronal damage, and exacerbation of diabetes, suggesting that interindividual variations in the green tea effect are large. This review will focus on the effect of green tea catechins extracted from the Camellia sinensis plant on type 2 diabetes and obesity, and the possible mechanistic explanation for the experimental results mainly from our laboratory. It is hoped that green tea can be consumed in a suitable manner as a supplement to prevent the development of type 2 diabetes and obesity.

• Clinical and Experimental Pediatrics
• /
• 제49권7호
• /
• pp.710-717
• /
• 2006

Type 2 diabetes mellitus in children and adolescents has been increasing for last 10 years. The increase in frequency of type 2 diabetes appears to parallel the increase in prevalence and severity of obesity in children and adolescents. The metabolic syndrome, cluster of potent risk factors for atherosclerotic cardiovascular disease and type 2 diabetes, consists of insulin resistance, obesity, hypertension and hyperlipidemia. The atherosclerotic cardiovascular disease are rarely seen in the young, but the pathologic processes and risk factors are associated its development have been shown to begin during childhood. In pediatrician it is important to recognize early and treat aggressively for prevention of future cardiovascular disease in children and adolescents with metabolic syndrome.

• 한방비만학회지
• /
• 제21권1호
• /
• pp.42-48
• /
• 2021

Objectives: The purpose of this study was to review the studies of the wild ginseng complex pharmacopuncture related to obesity treatment. Methods: We searched the papers with key words of 'wild ginseng complex pharmacopuncture', 'wild ginseng pharmacopuncture', 'obesity', 'fat', 'weight' in Oriental medicine Advanced Searching Integrated System, KRpia, Koreanstudies Information Service System, Research Information Sharing Service, KoreaMed and PubMed, Scopus. We classified the papers by year, content and study type. Results: There were 7 studies about the wild ginseng pharmacopuncture related to obesity treatment. Cell studies were excluded because they were not related to obesity. Analysis of 3 animal experiments and 4 clinical studies were conducted to describe each research subject, method, and research results. Conclusion: More interest and further research will be needed on wild ginseng pharmacopuncture related to obesity treatment in the Korean medicine to achieve clinical application and to develop treatment protocols for the obesity disease.

• 한방재활의학과학회지
• /
• 제26권1호
• /
• pp.49-61
• /
• 2016

Objectives To analyze the latest trend through the domestic studies of obesity and support further studies and clinical trials. Methods The theses were searched through KIOM OASIS (http://oasis.kiom.re.kr), The Journal of Society of Korean Medicine for Obesity Research, The Journal of Korean Medicine Rehabilitation. Then, domestic studies were gathered and classified by year, journal and type. Results 92 theses were included. The theses were constantly published every year. According to the analyzing by journals, the most published journal was The Journal of Society of Korean Medicine for Obesity Research. Through the analysis of type, 19 clinical studies and 11 case reports were found. The result of 43 theses analyzing survey and examination numerical value, the study of relationship between obesity and body index is the most published. Among 19 literary studies, 11 studies were searched domestic thesis, 2 studies were searched foreign thesis, 5 studies were searched domestic and foreign thesis simultaneously. Conclusions We need to effort to supplement the statistical error and the topic needs to be diverse. The sustainable research of The human body-oriented obesity studies is required.

• 대한한방소아과학회지
• /
• 제20권2호
• /
• pp.35-44
• /
• 2006

Objective : As today obese children have increased rapidly in Korea, the interest has been much increased. And parents concern about the effect of Herbal Medication(HM) on gaining weight. Therefore we had a retrospective study HM and obesity for children. Method : We examined medical record of 38 patients who visited to Department of Pediatrics in 00 medical center from 2002 to 2006 and took HM. Their Hight, Weight, Obesity Index(OI) were estimated at two points: before and after HM treatment. And they were divided into two groups according to the HM type and analyzed for differences of OI. Result : There were no significant changes in 38 patients's OI before and after treatment. But only one case gained over weight(OI: 21.31). OI increased slightly after treatment but there were not statistically significance. OI according to the HM type had slightly difference but there were not statistically significance. There were no connections between HM type, the number of days taking HM and changes of OI. Conclusion : On the basis of this study, we thought there were no connections between HM and obesity for children. But this study's cases are small in number so more study is need.

• 한방비만학회지
• /
• 제7권2호
• /
• pp.1-14
• /
• 2007

Objective The purpose of this study is to work on the direction of the study with regard to the sarcopenic obesity. Methods We searched articles relative to sarcopenic obesity in the KyungHee University Meta-analysis database. We classified articles according to type of study and subject clinical characteristics, assessment, medical complications and treatment. Results and Conclusion Data from this pilot study showed that sarcopenic obesity is associated with metabolic abnormality, cancer, increased frailty, physical disability and inflammatory markers. Therefore, clinical studies are needed to demonstrate the effectiveness and safety of management for sarcopenic obesity.

• 비만대사연구학술지
• /
• 제2권2호
• /
• pp.54-63
• /
• 2023

Estrogen is crucial in regulating food intake, energy expenditure, glucose metabolism, and lipid metabolism. During menopause, the decline in estrogen levels predisposes women to weight gain, abdominal obesity, insulin resistance, type 2 diabetes, hypertension, and cardiovascular disease (CVD). Menopausal hormone therapy (MHT) prevents weight gain, improves lipid metabolism by lowering low-density lipoprotein cholesterol while raising high-density lipoprotein cholesterol, and delays the onset of type 2 diabetes in menopausal women. The effect of MHT on CVD in menopausal women remains controversial. The Women's Health Initiative study was terminated prematurely after it revealed that hormone administration increased the risk of myocardial infarction, stroke, and thromboembolism. However, some studies have found that MHT had no effect or decreased the risk of CVD. The inconsistent results were likely due to multiple factors, including the timing of hormone therapy initiation, duration of therapy, type and dosage, and presence or absence of CVD risk factors at the start of treatment. Despite its benefits in terms of managing weight gain and reducing the risk of type 2 diabetes, dyslipidemia, and CVD associated with obesity, it is not recommended as the primary therapy for weight loss or diabetes prevention. MHT is primarily indicated for postmenopausal women, who are likely to benefit from its potential to prevent weight gain and improve lipid metabolism.

• 한국융합학회논문지
• /
• 제13권5호
• /
• pp.509-515
• /
• 2022

1인 가구의 고용형태에 따라 비만 및 고혈압 유병의 영향요인에 차이가 있는지를 확인하고자, 경제활동을 하는 20세에서 59세까지의 1인 가구를 정규직, 비정규직으로 분류하여 층화추출 후 질병 유무, 경제적 특성, 건강행태 등을 조사하였다(n=566). 고혈압과 비만 여부에 대해서 각각 로지스틱 회귀분석 결과, 고혈압에는 고용형태와 관련 없이 연령과 비만도가 높을수록 유의적으로 정(+)의 영향을 주었으며, 특히 비정규직의 경우 소득이 낮을수록 고혈압을 갖고 있는 경우가 많았다(p<0.001). 비만 유병률은 고용형태와 관련 없이 여성의 경우 남성에 비해서 유의적으로 더 낮았고, 특히 비정규직은 저녁식사의 충실도가 낮을수록 비만 유병률이 높았다(p<0.001). 이러한 결과로 볼 때, 소득 수준이 낮고 저녁식사의 충실도가 낮은 비정규직 1인 가구 대상으로 고혈압 및 비만 등의 만성질환 관리를 위한 방안이 더욱 실질적으로 제시되어야 할 것으로 사료된다.

• 패션비즈니스
• /
• 제15권1호
• /
• pp.103-114
• /
• 2011

This study is to provide basic information on clothing fitness necessary to develop apparel products for Korean companies that want to enter or have already made inroads into the Chinese market. In an effort to serve this purpose, a standard upper torso body model for Chinese women was established by applying the Rohrer Index and Size Designation of Clothes - Women of GB/T 1335.2-1997 to Chinese women in their 20s to determine body types and its characteristics. First, according to the result of applying the Rohrer Index to categorize body types, Type 1 showed the longest vertical body length and a short horizontal length with the lowest degree of flatness. Type 2 was a standard body type with a height of 158.73cm, weight of 53.02kg and the Rohrer Index of 1.32. Type 3 had a thick and flat body shape that had the highest degree of flatness and the shortest vertical length in its upper torso among all three types of body. Second, F-test was conducted on 4 distinctive body types obtained from comparing obesity scores to verify differences in body shapes for different degree of obesity. The test result indicated significant differences in 3 of the 4 body types and showed different structural components for different degree of obesity. Third, the result of comparing correlational distributions of body types and height range, and body types and degree of obesity for all and specified age groups revealed that about 33.30% of the body types appeared in Type2-A followed by 20.18% in Type1-A, 18.40% in Type2-Y and 7.91% in Type1-Y respectively. Body types and degree of obesity for two different age groups were most frequent in Type2-A. For the group of young women in their early 20s appeared the most in Type2-A, Type1-A, Type2-Y and Type 1-Y respectively and young women in late 20s were frequent in the order of Type2-A, Type2-Y, Type1-A and Type1-Y.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제12권sup1호
• /
• pp.118-126
• /
• 2009

The incidence of childhood obesity has increased dramatically. Childhood obesity is an increasing health problem because of its strong associations with chronic health problems in children and adults. These health problems significantly contribute to the development of common chronic diseases in later life, including hypertension, type2 diabetes, hyperinsulinemia, coronary heart disease, and other psychological disorders. So it is an important issue to prevent and treat obesity during childhood and adolescent. Diet and exercise are the cornerstones of treatment for obesity and related complications. For obese children, some clinical trials have shown improvement with diet, exercise, and /or behavioral interventions. Promising interventions for high-risk individuals, such as bariatric surgery and novel pharmacological agents, also require rigorous assessment with attention to long-term patient important outcomes. There are various pharmacological approaches to the treatment of obesity in the adolescent population some of which have FDA approval. In the article we discuss pharmacological approaches to guide the treatment of obesity in the pediatric population, including risks of treatment, monitoring of potential side effects.